Broad in vitro efficacy of plant-derived betulinic acid against cell lines derived from the most prevalent human cancer types

Cancer Letters

Volumn 251, Issue 1, 2007, Pages 132-145

  Kessler, Jan H ^a   Mullauer, Franziska B ^a   de Roo, Guido M ^b   Medema, Jan Paul ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Apoptosis; Betulinic acid; Breast cancer; Cervical cancer; Chemotherapy; Colorectal cancer; Lung cancer; Prostate cancer

Indexed keywords

BETULIC ACID; PROPIDIUM IODIDE; TRITERPENE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CANCER REGRESSION; CELL DEATH; CELL VIABILITY; COLONY FORMATION; COLORECTAL CANCER; CONTROLLED STUDY; DRUG EFFICACY; DRUG SENSITIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA; LEUKEMIA CELL; LUNG CANCER; MELANOMA; NEUROECTODERM TUMOR; PRIORITY JOURNAL; PROSTATE CANCER; UTERINE CERVIX CANCER;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL SURVIVAL; CELLS, CULTURED; COLORECTAL NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; JURKAT CELLS; LUNG NEOPLASMS; MALE; NEOPLASMS; POLY(ADP-RIBOSE) POLYMERASES; PROSTATIC NEOPLASMS; TRITERPENES; UTERINE CERVICAL NEOPLASMS;

ANIMALIA; MUS;

EID: 34247120086     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2006.11.003     Document Type: Article

References (45)

1. Pisha E., Chai H., Lee I.S., Chagwedera T.E., Farnsworth N.R., Cordell G.A., Beecher C.W., Fong H.H., Kinghorn A.D., Brown D.M., Wani M.C., Wall M.E., Hieken T.J., Das Gupta T.K., and Pezzuto J.M. Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis. Nat. Med. 1 (1995) 1046-1051
2. Mukherjee P.K., Saha K., Das J., Pal M., and Saha B.P. Studies on the anti-inflammatory activity of rhizomes of Nelumbo nucifera. Planta. Med. 63 (1997) 367-369
3. Fujioka T., Kashiwada Y., Kilkuskie R.E., Cosentino L.M., Ballas L.M., Jiang J.B., Janzen W.P., Chen I.S., and Lee K.H. Anti-AIDS agents. 11. Betulinic acid and platanic acid as anti-HIV principles from Syzigium claviflorum and the anti-HIV activity of structurally related triterpenoids. J. Nat. Prod. 57 (1994) 243-247
4. Li F., Goila-Gaur R., Salzwedel K., Kilgore N.R., Reddick M., Matallana C., Castillo A., Zoumplis D., Martin D.E., Orenstein J.M., Allaway G.P., Freed E.O., and Wild C.T. PA-457: a potent HIV inhibitor that disrupts core condensation by targeting a late step in Gag processing. Proc. Natl. Acad. Sci. USA 100 (2003) 13555-13560
5. Eiznhamer D.A., and Xu Z.Q. Betulinic acid: a promising anticancer candidate. IDrugs 7 (2004) 359-373
6. Cichewicz R.H., and Kouzi S.A. Chemistry, biological activity, and chemotherapeutic potential of betulinic acid for the prevention and treatment of cancer and HIV infection. Med. Res. Rev. 24 (2004) 90-114
7. Kim D.S., Chen Z., Nguyen T., Pezzuto J.M., Qiu S., and Lu Z. A concise semi-synthetic approach to betulinic acid from betulin. Syn. Commun. 27 (2003) 1607-1612
8. Hayek E.W.H., Jordis U., Moche W., and Sauter F. A bicentennial of betulin. Phytochemistry 28 (1989) 2229-2242
9. O'Connel M.M., Bentley M.D., Campbell C.S., and Cole B.J.W. Betulin and Lupeol in bark from four white-barked birches. Phytochemistry 27 (1998) 2175-2176
10. Fulda S., Friesen C., Los M., Scaffidi C., Mier W., Benedict M., Nunez G., Krammer P.H., Peter M.E., and Debatin K.M. Betulinic acid triggers CD95 (APO-1/Fas)- and p53-independent apoptosis via activation of caspases in neuroectodermal tumors. Cancer Res. 57 (1997) 4956-4964
11. Schmidt M.L., Kuzmanoff K.L., Ling-Indeck L., and Pezzuto J.M. Betulinic acid induces apoptosis in human neuroblastoma cell lines. Eur. J. Cancer 33 (1997) 2007-2010
12. Fulda S., Jeremias I., Steiner H.H., Pietsch T., and Debatin K.M. Betulinic acid: a new cytotoxic agent against malignant brain-tumor cells. Int. J. Cancer 82 (1999) 435-441
13. Wick W., Grimmel C., Wagenknecht B., Dichgans J., and Weller M. Betulinic acid-induced apoptosis in glioma cells: a sequential requirement for new protein synthesis, formation of reactive oxygen species, and caspase processing. J. Pharmacol. Exp. Ther. 289 (1999) 1306-1312
14. Thurnher D., Turhani D., Pelzmann M., Wannemacher B., Knerer B., Formanek M., Wacheck V., and Selzer E. Betulinic acid: a new cytotoxic compound against malignant head and neck cancer cells. Head Neck 25 (2003) 732-740
15. Zuco V., Supino R., Righetti S.C., Cleris L., Marchesi E., Gambacorti-Passerini C., and Formelli F. Selective cytotoxicity of betulinic acid on tumor cell lines, but not on normal cells. Cancer Lett. 175 (2002) 17-25
16. Ehrhardt H., Fulda S., Fuhrer M., Debatin K.M., and Jeremias I. Betulinic acid-induced apoptosis in leukemia cells. Leukemia 18 (2004) 1406-1412
17. Selzer E., Pimentel E., Wacheck V., Schlegel W., Pehamberger H., Jansen B., and Kodym R. Effects of betulinic acid alone and in combination with irradiation in human melanoma cells. J. Invest. Dermatol. 114 (2000) 935-940
18. Sandberg F., Dutschewska H., Christov V., and Spassov S. Spondianthus preussii var. glaber Engler. Pharmacological screening and occurrence of triterpenes. Acta Pharm. Suec. 24 (1987) 253-256
19. Fulda S., Scaffidi C., Susin S.A., Krammer P.H., Kroemer G., Peter M.E., and Debatin K.M. Activation of mitochondria and release of mitochondrial apoptogenic factors by betulinic acid. J. Biol. Chem. 273 (1998) 33942-33948
20. Fulda S., Susin S.A., Kroemer G., and Debatin K.M. Molecular ordering of apoptosis induced by anticancer drugs in neuroblastoma cells. Cancer Res. 58 (1998) 4453-4460
21. Tan Y., Yu R., and Pezzuto J.M. Betulinic acid-induced programmed cell death in human melanoma cells involves mitogen-activated protein kinase activation. Clin. Cancer Res. 9 (2003) 2866-2875
22. Chowdhury A., Mandal S., Mittra B., Sharma S., Mukhopadhyay S., and Majumder H. Betulinic acid, a potent inhibitor of eukaryotic topoisomerase I: identification of the inhibitory step, the major functional group responsible and development of more potent derivatives. Med. Sci. Monit. 8 (2002) BR254-BR265
23. Syrovets T., Buchele B., Gedig E., Slupsky J.R., and Simmet T. Acetyl-boswellic acids are novel catalytic inhibitors of human topoisomerases I and IIalpha. Mol. Pharmacol. 58 (2000) 71-81
24. Jemal A., Siegel R., Ward E., Murray T., Xu J., Smigal C., and Thun M.J. Cancer statistics, 2006. CA Cancer J. Clin. 56 (2006) 106-130
25. Kessler J.H., Beekman N.J., Bres-Vloemans S.A., Verdijk P., van Veelen P.A., Kloosterman-Joosten A.M., Vissers D.C., ten Bosch G.J., Kester M.G., Sijts A., Drijfhout J.W., Ossendorp F., Offringa R., and Melief C.J.M. Efficient identification of novel HLA-A(*)0201-presented cytotoxic T lymphocyte epitopes in the widely expressed tumor antigen PRAME by proteasome-mediated digestion analysis. J. Exp. Med. 193 (2001) 73-88
26. Bots M., Kolfschoten I.G., Bres S.A., Rademaker M.T., de Roo G.M., Kruse M., Franken K.L., Hahne M., Froelich C.J., Melief C.J., Offringa R., and Medema J.P. SPI-CI and SPI-6 cooperate in the protection from effector cell-mediated cytotoxicity. Blood 105 (2005) 1153-1161
27. Medema J.P., de Jong J., Peltenburg L.T., Verdegaal E.M., Gorter A., Bres S.A., Franken K.L., Hahne M., Albar J.P., Melief C.J., and Offringa R. Blockade of the granzyme B/perforin pathway through overexpression of the serine protease inhibitor PI-9/SPI-6 constitutes a mechanism for immune escape by tumors. Proc. Natl. Acad. Sci. USA 98 (2001) 11515-11520
28. Hendriks J., Planelles L., Jong-Odding J., Hardenberg G., Pals S.T., Hahne M., Spaargaren M., and Medema J.P. Heparan sulfate proteoglycan binding promotes APRIL-induced tumor cell proliferation. Cell Death. Differ. 12 (2005) 637-648
29. de Bruin E.C., Meersma D., de Wilde J., den O., Schipper I.E.M., Medema J.P., and Peltenburg L.T. A serine protease is involved in the initiation of DNA damage-induced apoptosis. Cell Death. Differ. 10 (2003) 1204-1212
30. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics, 2002. CA Cancer J. Clin. 55 (2005) 74-108
31. Jansen K.U. Vaccines against cervical cancer. Expert. Opin. Biol. Ther. 4 (2004) 1803-1809
32. Sarek J., Klinot J., Dzubak P., Klinotova E., Noskova V., Krecek V., Korinkova G., Thomson J.O., Janost'akova A., Wang S., Parsons S., Fischer P.M., Zhelev N.Z., and Hajduch M. New lupane derived compounds with pro-apoptotic activity in cancer cells: synthesis and structure-activity relationships. J. Med. Chem. 46 (2003) 5402-5415
33. You Y.J., Kim Y., Nam N.H., and Ahn B.Z. Synthesis and cytotoxic activity of A-ring modified betulinic acid derivatives. Bioorg. Med. Chem. Lett. 13 (2003) 3137-3140
34. Kim J.Y., Koo H.M., and Kim D.S. Development of C-20 modified betulinic acid derivatives as antitumor agents. Bioorg. Med. Chem. Lett. 11 (2001) 2405-2408
35. Bots M., VAN Bostelen L., Rademaker M.T., Offringa R., and Medema J.P. Serpins prevent granzyme-induced death in a species-specific manner. Immunol. Cell Biol. 84 (2006) 79-86
36. Belmokhtar C.A., Hillion J., Dudognon C., Fiorentino S., Flexor M., Lanotte M., and Segal-Bendirdjian E. Apoptosome-independent pathway for apoptosis. Biochemical analysis of APAF-1 defects and biological outcomes. J. Biol. Chem. 278 (2003) 29571-29580
37. Xue L.Y., Chiu S.M., and Oleinick N.L. Photodynamic therapy-induced death of MCF-7 human breast cancer cells: a role for caspase-3 in the late steps of apoptosis but not for the critical lethal event. Exp. Cell Res. 263 (2001) 145-155
38. Amico V., Barresi V., Condorelli D., Spatafora C., and Tringali C. Antiproliferative terpenoids from almond hulls (Prunus dulcis): identification and structure-activity relationships. J. Agric. Food Chem. 54 (2006) 810-814
39. Mukherjee R., Jaggi M., Rajendran P., Srivastava S.K., Siddiqui M.J., Vardhan A., and Burman A.C. Synthesis of 3-O-acyl/3-benzylidene/3-hydrazone/ 3-hydrazine/17-carboxyacryloyl ester derivatives of betulinic acid as anti-angiogenic agents. Bioorg. Med. Chem. Lett. 14 (2004) 3169-3172
40. Urban M., Sarek J., Klinot J., Korinkova G., and Hajduch M. Synthesis of A-seco derivatives of betulinic acid with cytotoxic activity. J. Nat. Prod. 67 (2004) 1100-1105
41. Raghuvar Gopal D.V., Narkar A.A., Badrinath Y., Mishra K.P., and Joshi D.S. Protection of Ewing's sarcoma family tumor (ESFT) cell line SK-N-MC from betulinic acid induced apoptosis by alpha-dl-tocopherol. Toxicol. Lett. 153 (2004) 201-212
42. Raghuvar Gopal D.V., Narkar A.A., Badrinath Y., Mishra K.P., and Joshi D.S. Betulinic acid induces apoptosis in human chronic myelogenous leukemia (CML) cell line K-562 without altering the levels of Bcr-Abl. Toxicol. Lett. 155 (2005) 343-351
43. Kwon H.J., Shim J.S., Kim J.H., Cho H.Y., Yum Y.N., Kim S.H., and Yu J. Betulinic acid inhibits growth factor-induced in vitro angiogenesis via the modulation of mitochondrial function in endothelial cells. Jpn. J. Cancer Res. 93 (2002) 417-425
44. Fulda S., Jeremias I., and Debatin K.M. Cooperation of betulinic acid and TRAIL to induce apoptosis in tumor cells. Oncogene 23 (2004) 7611-7620
45. Fulda S., and Debatin K.M. Sensitization for anticancer drug-induced apoptosis by betulinic acid. Neoplasia. 7 (2005) 162-170